1st Quarter - Report
BLUEBIRD STRATEGIES for PEAR THERAPEUTICS
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Increase awareness of clinical use of FDA cleared prescription digital therapeutics and Medicare coverage.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN KEVIN BRENNAN | — |
Medicare/Medicaid MMM
H.R. 5333, Ensuring Patient Access to Critical Breakthrough Products Act of 2019, as it relates to Medicare coverage. S. 3532, Prescription Digital Therapeutics to Support Recovery Act, as it relates to Medicare coverage.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN KEVIN BRENNAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.